Herpesviridae Infections  >>  Cytovene (ganciclovir)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cytovene (ganciclovir) / Roche
NCT00730769: Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients

Completed
4
21
Europe
Single arm (ganciclovir and valganciclovir), Ganciclovir (Cymevene®), Valganciclovir (Valcyte®)
Salvador Gil-Vernet, Roche Pharma AG
Cytomegalovirus Infection
07/07
07/08
NCT00431353: VICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant Recipients

Completed
4
325
Canada, Europe, RoW
Ganciclovir, valganciclovir [Valcyte]
Hoffmann-La Roche
Cytomegalovirus Infections
08/08
08/08
NCT01663740: A Study on Spermatogenesis in Male Renal Transplant Recipients Receiving Valganciclovir (Valcyte®) Versus Untreated Matched Controls

Completed
4
59
US, RoW
Valganciclovir, Valcyte®
Hoffmann-La Roche
Cytomegalovirus Infections
09/15
12/16

Download Options